Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9134152 | 0.85 | TDP1 (0.33) | TDP1 | |
| SCHEMBL13822335 | 0.82 | TDP1 (0.31) | TDP1 | |
| SCHEMBL9131939 | 0.81 | TDP1 (0.36) | TDP1 | |
| SCHEMBL9131522 | 0.81 | TSHR (0.31) | TDP1 | |
| SCHEMBL9132338 | 0.81 | TDP1 (0.30) | TDP1 | |
| SCHEMBL13822546 | 0.80 | TSHR (0.34) | — | |
| SCHEMBL13822453 | 0.80 | TSHR (0.34) | — | |
| SCHEMBL13822477 | 0.80 | TSHR (0.34) | — | |
| SCHEMBL13822399 | 0.78 | EBP (0.32) | LSS | |
| SCHEMBL6113837 | 0.77 | LSS (0.33) | LSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120308486-A1 | Fragrance and/or flavoring compositions containing dioxolanes | SYMRISE AG (DE) | 2012-12-06 | — | — | US | claimed |
| US-20120308486-A1 | Fragrance and/or flavoring compositions containing dioxolanes | SYMRISE AG (DE) | 2012-12-06 | — | — | US | disclosed |
| EP-2411377-A2 | HETEROATOM-CONTAINING POLYMERS AND METATHESIS POLYMERIZATION METHODS FOR MAKING SAME | Medtronic, Inc (US) | 2012-02-01 | — | — | EP | disclosed |
| WO-2010111211-A2 | HETEROATOM-CONTAINING POLYMERS AND METATHESIS POLYMERIZATION METHODS FOR MAKING SAME | MEDTRONIC, INC. (US) | 2010-09-30 | — | — | WO | disclosed |
| US-20100240852-A1 | HETEROATOM-CONTAINING POLYMERS AND METATHESIS POLYMERIZATION METHODS FOR MAKING SAME | MEDTRONIC, INC. (US) | 2010-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120308486-A1 | Fragrance and/or flavoring compositions containing dioxolanes | FDFT1, DECR1, DOHH | TDP1 1510/4885LSS 676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.